Methylphenidate Hydrochloride (la) Capsule, Extended Release
Product Images NDC 75907-049

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (la) (NDC 75907-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp 60mg Carton (Meth 04)

Pdp 60mg Carton (Meth 04)
Methylphenidate Hydrochloride Extended-Release Capsules (LA) 60 mg bottle label from Dr. Reddy's Laboratories Inc. The label states this prescription oral capsule comes in a package of 30 capsules. It includes storage instructions, a barcode, a note for pharmacists to dispense with a Medication Guide, and contact information.*
FDA Label Image

Pdp-10mg Carton (Meth 05)

Pdp-10mg Carton (Meth 05)
Label for Methylphenidate Hydrochloride Extended-Release Capsules (LA) 10 mg, an oral prescription drug by Dr. Reddy's Laboratories Inc. The label states 'Once Daily' use, includes the NDC code 76907-049, and indicates a quantity of 100 capsules. It contains storage instructions, distributor information, and a pharmacist note for dispensing with a Medication Guide.*
FDA Label Image

Pdp 20mg Carton (Meth 06)

Pdp 20mg Carton (Meth 06)
Label for Methylphenidate Hydrochloride Extended-Release Capsules (LA) 20 mg by Dr. Reddy's Laboratories Inc. The label states this is a once daily oral capsule, prescription only, with 100 capsules per container. It includes storage instructions, distribution details, and a toll-free contact number for questions.*
FDA Label Image

Pdp 30mg Carton (Meth 07)

Pdp 30mg Carton (Meth 07)
Label for Methylphenidate Hydrochloride Extended-Release Capsules (LA) 30 mg by Dr. Reddy's Laboratories Inc. The label includes dosage strength, route as oral capsules, package size of 100 capsules, and distributor contact information. The label features a barcode and instructions to dispense with a Medication Guide.*
FDA Label Image

Pdp 40mg Carton (Meth 08)

Pdp 40mg Carton (Meth 08)
Methylphenidate Hydrochloride Extended-Release Capsules (LA) 40 mg label for oral use, distributed by Dr. Reddy's Laboratories Inc. The label includes the NDC 75907-052-01, dosing information, storage instructions, a barcode, and packaging quantity of 100 capsules. The design features blue and green text on a white background with the Dr. Reddy's logo.*
FDA Label Image

Chemical Structure (Methylphenidate 01)

Chemical Structure (Methylphenidate 01)
Chemical structure of Methylphenidate Hydrochloride showing the molecular arrangement including a benzene ring, ester group (COOCH3), and a piperidine ring, alongside the hydrochloride (HCl) component.*
FDA Label Image

Figure 1 (Methylphenidate 02)

Figure 1 (Methylphenidate 02)
Pharmacokinetic profile graph comparing mean plasma levels of d-methylphenidate over 24 hours. It depicts levels for Methylphenidate Hydrochloride Extended-Release Capsules (LA) 40 mg once daily versus Methylphenidate Hydrochloride Tablets 20 mg taken twice daily. The y-axis represents plasma levels in ng/mL and the x-axis represents time in hours.*
FDA Label Image

Principal Display Panel (Methylphenidate 03)

Principal Display Panel (Methylphenidate 03)
A bar chart comparing mean final scores versus mean baseline scores between Methylphenidate HCl ER Capsules (LA) and placebo groups. The vertical axis represents the mean score difference, with error bars indicating standard error of the mean. Methylphenidate group shows a negative mean score, while the placebo group shows a positive mean score.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.